Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,778 | 32,780 | 21,215 | 1,641 | N/A |
| Marketable Securities | 88,676 | 76,138 | 11,341 | N/A | N/A |
| Receivables | N/A | N/A | 135 | 86 | N/A |
| TOTAL | $141,017 | $110,480 | $33,431 | $2,244 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 540 | 210 | 30 | N/A | N/A |
| Other Non-Current Assets | 1,383 | 305 | 1,204 | 0 | 0 |
| TOTAL | $1,923 | $515 | $1,234 | $N/A | $N/A |
| Total Assets | $142,940 | $110,995 | $34,665 | $2,244 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,313 | 2,021 | 714 | 418 | 0 |
| Accrued Expenses | 9,555 | 4,864 | 3,188 | 351 | N/A |
| Other current liabilities | N/A | N/A | N/A | 4,154 | N/A |
| TOTAL | $11,868 | $6,885 | $3,902 | $4,923 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5 | 32 | 8 | 0 | 0 |
| TOTAL | $74 | $32 | $8 | $N/A | $N/A |
| Total Liabilities | $11,942 | $6,917 | $3,910 | $4,923 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,943 | 20,371 | N/A | N/A | N/A |
| Retained earnings | -161,389 | -100,673 | -127,072 | -59,588 | N/A |
| Other shareholders' equity | -396 | -218 | 157,827 | 56,909 | 0 |
| TOTAL | $130,998 | $104,078 | $30,755 | $-2,680 | $N/A |
| Total Liabilities And Equity | $142,940 | $110,995 | $34,665 | $2,244 | $0 |